Amendment in Export Policy of Hydroxychloroquine API and its Formulations. - 13/2015-2020 - Foreign Trade Policy

MINISTRY OF COMMERCE AND INDUSTRY (Department of Commerce) (DIRECTORATE GENERAL OF FOREIGN TRADE) NOTIFICATION No. 13/2015-2020 New Delhi, the 18th June, 2020 Subject : Amendment in Export Policy of Hydroxychloroquine API and its Formulations. S.O. 1963(E).- In exercise of powers conferred by Section 3 of the Foreign Trade (Development Regulation) Act, 1992 (No. 22 of 1992) , as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20 , the Central Government hereby makes the following amendments in the Notification No. 54 dated 25.03.2020 amending the Schedule 2 of the ITCHS Export Policy related to export of Hydroxychloroquine and its formulations, with immediate effect: S. No. ITC HS Codes Description Present Policy Revised Policy 207 E 29334900 29333990 29339900 Hydroxychloroquine Prohibited Free 207 F 30049059 30049099 Formulations made from Hydroxychloroquine Prohibited Free 2 . Effect of this Notification: The Notification No. 54 dated 25.03.2020 has been amended to change the export policy of Hydroxychloroquine API and its formulations from Prohibited to Free , with immediate effect. [F. No. 01/91/180/21/AM20/EC/E-21154] AMIT YADAV, Director General of Foreign Trade Ex-Officio Addl. Secy.